The effects of prostate cancer in urine

The effects of prostate cancer in urine

Simple test may detect early prostate cancer

Scientists said they are on the verge of a thorough testing of urine can monitor the effects of prostate cancer that is killing thousands of people each year And prostate cancer can be treated if the person in the early stage of development, but that healing often becomes intractable when it begins to show symptoms of cancer However, American researchers have discovered a new way to monitor cancer at an early stage depending on the gene technology Dr Paul Cairns of the "center of Fox to fight cancer," Philadelphia: This is the first time proved the possibility of someone monitoring the particles in the urine of prostate cancer The current experiments to track the components of blood called a generator for your anti-prostate This technique has been successful in saving the lives of many people, but failed to monitor the number of cases of cancer, not to mention the error referring to several cases of cancer It is noteworthy that the urine samples used in the detection of bladder cancer and kidney, but they were not used in the diagnosis of prostate cancer Was conducted by Dr. Cairns and his team tested tumors and samples from the urine of 28 people have prostate cancer, injuries can be treated by surgery Precise technical They adopted the technique to test the precision for early detection of genetic transformation was found in ninety percent of cases of prostate cancer, but was not found in normal tissues Has shown 22 of the incidence of tumors for the presence of genetic transformation. In six of these cases, tests of urine samples indicated the presence of the shift mentioned He stressed that given that it happened in some cases the effects of that leak into the urine of cancer Dr. Cairns and stressed the need for more research to develop this technology, but pointed out that it can be implemented soon and will not be an expensive way to monitor prostate cancer Cairns said: If we can early detection of prostate cancer for a third of patients, it would be optimism that we can raise the proportion of disclosure, and through continuous research and development of molecular technology